Upon completion of this activity, participants should be able to:
Summarize the latest evidence and recommendations in lung cancer screening, including advances in early detection methods.
Describe the evolving role of interventional pulmonary procedures in the diagnosis and management of lung cancer.
Evaluate emerging applications of artificial intelligence and social media in improving lung cancer care delivery, education, and patient engagement.
Analyze the multidisciplinary treatment strategies for non-small cell lung cancer (NSCLC), including surgical resection, neoadjuvant/adjuvant therapies, targeted treatments, immunotherapy, and novel systemic therapies.
Discuss current updates in the therapeutic landscape for small cell lung cancer (SCLC), with a focus on integration into clinical practice.